PL1778710T3 - Pochodne tanaprogetu, metabolity i ich zastosowania - Google Patents

Pochodne tanaprogetu, metabolity i ich zastosowania

Info

Publication number
PL1778710T3
PL1778710T3 PL05779751T PL05779751T PL1778710T3 PL 1778710 T3 PL1778710 T3 PL 1778710T3 PL 05779751 T PL05779751 T PL 05779751T PL 05779751 T PL05779751 T PL 05779751T PL 1778710 T3 PL1778710 T3 PL 1778710T3
Authority
PL
Poland
Prior art keywords
metabolites
derivatives
tanaproget
tanaproget derivatives
samples
Prior art date
Application number
PL05779751T
Other languages
English (en)
Inventor
Li Shen
Kelly Keating
Oliver Mcconnel
William Demaio
Appavu Chandrasekaran
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35447234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1778710(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL1778710T3 publication Critical patent/PL1778710T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL05779751T 2004-08-13 2005-08-11 Pochodne tanaprogetu, metabolity i ich zastosowania PL1778710T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60125404P 2004-08-13 2004-08-13
PCT/US2005/028424 WO2006020712A1 (en) 2004-08-13 2005-08-11 Tanaproget derivatives, metabolites, and uses thereof
EP05779751A EP1778710B1 (en) 2004-08-13 2005-08-11 Tanaproget derivatives, metabolites, and uses thereof

Publications (1)

Publication Number Publication Date
PL1778710T3 true PL1778710T3 (pl) 2012-06-29

Family

ID=35447234

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05779751T PL1778710T3 (pl) 2004-08-13 2005-08-11 Pochodne tanaprogetu, metabolity i ich zastosowania

Country Status (16)

Country Link
US (3) US7569679B2 (pl)
EP (1) EP1778710B1 (pl)
JP (2) JP4980217B2 (pl)
CN (1) CN101001863B (pl)
AT (1) ATE541853T1 (pl)
AU (1) AU2005272854B2 (pl)
BR (1) BRPI0514273A (pl)
CA (1) CA2575737C (pl)
CY (1) CY1112681T1 (pl)
DK (1) DK1778710T3 (pl)
ES (1) ES2380219T3 (pl)
MX (1) MX2007001812A (pl)
PL (1) PL1778710T3 (pl)
PT (1) PT1778710E (pl)
SI (1) SI1778710T1 (pl)
WO (1) WO2006020712A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
CA2575737C (en) * 2004-08-13 2013-09-24 Wyeth Tanaproget derivatives, metabolites, and uses thereof
DE602006012972D1 (de) * 2005-04-28 2010-04-29 Wyeth Corp Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung
PE20061322A1 (es) * 2005-04-28 2006-12-28 Wyeth Corp Forma purificada de tanaproget
JP5149161B2 (ja) * 2005-04-28 2013-02-20 ワイス・エルエルシー ミクロ化タナプロゲットを含む組成物
BRPI0610431A2 (pt) * 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, processo para preparar uma composição, cápsula, e, kit farmacêutico
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
TW200716137A (en) 2005-06-09 2007-05-01 Wyeth Corp Tanaproget compositions containing ethinyl estradiol
WO2008021337A1 (en) * 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US20090197878A1 (en) * 2008-02-01 2009-08-06 Wyeth SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR
WO2014143617A1 (en) * 2013-03-14 2014-09-18 Teva Women's Health, Inc. Deuterium-enriched tanaproget and processes for its preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060A (en) * 1849-01-23 Register for hot-air furnaces
EP0671953A4 (en) * 1992-11-13 1996-01-10 Univ Ohio State Res Found C-GLYCOSIDE ANALOG OF N- (HYDROXYPHENYL) RETINAMIDE-O-GLUCURONID.
CA2343356A1 (en) * 1998-10-09 2000-04-20 Isotechnika, Inc. Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites
HUP0203332A3 (en) * 1999-05-04 2004-12-28 Wyeth Corp Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
PT1268453E (pt) * 2000-04-07 2006-10-31 Pfizer Prod Inc Metabolitos de agonista/antagonista de estrogenio
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
CN1662241A (zh) 2002-06-25 2005-08-31 惠氏公司 环硫代氨基甲酸酯衍生物在治疗与激素有关的病症中的用途
CN1665510A (zh) 2002-06-25 2005-09-07 惠氏公司 作为pr调节剂的环硫代氨基甲酸酯衍生物的衍生物和其用于治疗皮肤病的用途
AR049631A1 (es) 2004-04-27 2006-08-23 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos
CA2575737C (en) 2004-08-13 2013-09-24 Wyeth Tanaproget derivatives, metabolites, and uses thereof

Also Published As

Publication number Publication date
EP1778710A1 (en) 2007-05-02
AU2005272854B2 (en) 2012-04-26
PT1778710E (pt) 2012-04-12
CN101001863B (zh) 2012-10-10
WO2006020712A1 (en) 2006-02-23
ATE541853T1 (de) 2012-02-15
AU2005272854A1 (en) 2006-02-23
JP4980217B2 (ja) 2012-07-18
EP1778710B1 (en) 2012-01-18
JP2012121907A (ja) 2012-06-28
JP2008509917A (ja) 2008-04-03
CN101001863A (zh) 2007-07-18
US20130143827A1 (en) 2013-06-06
BRPI0514273A (pt) 2008-06-10
CA2575737C (en) 2013-09-24
SI1778710T1 (sl) 2012-05-31
ES2380219T3 (es) 2012-05-09
US8389698B2 (en) 2013-03-05
CY1112681T1 (el) 2016-02-10
US20090306000A1 (en) 2009-12-10
MX2007001812A (es) 2007-03-26
CA2575737A1 (en) 2006-02-23
US20060035843A1 (en) 2006-02-16
DK1778710T3 (da) 2012-04-16
US7569679B2 (en) 2009-08-04

Similar Documents

Publication Publication Date Title
CY1112681T1 (el) Παραγωγα ταναπρογετης, μεταβολιτες και χρησεις αυτων
SG152239A1 (en) Compounds for proteasome enzyme inhibition
NO20084777L (no) Trinnvise sementeringsfremgangsmater som brukes ved samtidig boring og fôring
TW200636245A (en) Colorimetric sensors constructed of diacetylene materials
SI1633697T1 (sl) Postopek za pripravo substituiranih 3-aril-butilaminskih spojin
EP1883840A4 (en) A rapid method for reservoir connectivity analysis using a fast marching method
EP1815101A4 (en) METHODS AND APPARATUS FOR DRILLING, COMPLETING AND CONFIGURING U-TUBE DRILLING HOLES
DK1792052T3 (da) Værktøj med indbygget magnetisk måling
GB2432609A (en) Method of expansion
DK2079706T3 (da) Fremgangsmåde til fremstilling af medetomidin og saltene deraf
TW200636075A (en) Detection of nucleic acid variation by cleavage-amplification method
NO20071927L (no) Peptidsyklisering.
GB2472533A (en) Methods and apparatus for collecting a downhole sample
NO20066078L (no) Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon
AU2003253440A1 (en) Method of diagnosing ovarian endometriosis
UA87487C2 (ru) Полиморфные формы габоксадола, агониста gabaа, способ их получения и применение
TW200616633A (en) CCI-779 derivatives and methods of making same
AU2003213960A1 (en) Methods for detecting ovarian cancer
EA200700766A1 (ru) Способ получения производных [1,4,5]-оксадиазепина
TW200619205A (en) A method for preparing irbesartan and intermediates thereof
PT1891104E (pt) Timosina alfa-1 ligada a fase sólida e sua síntese
MX2008001612A (es) Metodos para preparar acidos boronicos heterociclicos y derivados de los mismos.
SG142306A1 (en) Methods for neuroprotection
DK1948626T3 (da) Fremgangsmåde til fremstilling af delmopinol og derivater deraf
WO2006135812A3 (en) Method and apparatus for source synchronous testing